搜索





搜索





TScan Therapeutics Inc

TCRX

添加自选

0.355USD

+0.024+7.25%

收盘 09-22 16:00（美东）

23.72M总市值

亏损市盈率 TTM

盘后交易 18:05 (美东)0.359USD+0.007+1.99%

TScan Therapeutics Inc

0.355

+0.024+7.25%

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

概览

财务

股票评分

技术分析

预测

持股情况

股息

公司资料

财务摘要利润表资产负债表现金流量表公司收入财报公司估值风险评估

TCRX 利润表

您可以在这里找到TScan Therapeutics Inc的年度或季度收入报告，以深入了解TScan Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

营业总收入

-65.83%1.05M

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

营业收入

-65.83%1.05M

-54.77%982.00K

286.02%2.57M

139.37%2.51M

473.88%3.08M

283.57%2.17M

-90.78%665.00K

-73.01%1.05M

-82.97%536.00K

-91.68%566.00K

132.99%7.21M

15.58%3.89M

-22.39%3.15M

125.19%6.80M

8.44%3.10M

39.43%3.36M

42.42%4.06M

49.04%3.02M

258.99%2.85M

731.72%2.41M

--2.85M

--2.03M

--795.00K

--290.00K

--0.00

营业费用

-24.41%31.54M

-21.60%30.12M

-34.65%24.43M

17.50%39.56M

20.43%41.73M

20.29%38.42M

30.84%37.38M

17.59%33.67M

24.83%34.65M

8.10%31.94M

31.38%28.57M

43.60%28.64M

43.81%27.76M

54.01%29.55M

27.49%21.74M

9.24%19.94M

42.69%19.30M

92.90%19.18M

98.21%17.06M

144.66%18.25M

140.87%13.53M

76.45%9.95M

--8.61M

--7.46M

--5.62M

--5.64M

研发费用

-29.04%22.79M

-27.29%21.30M

-39.21%17.84M

18.41%31.10M

19.48%32.11M

17.82%29.29M

31.01%29.35M

15.48%26.26M

26.62%26.88M

14.13%24.86M

43.59%22.41M

51.29%22.74M

46.45%21.23M

48.26%21.78M

23.76%15.60M

5.81%15.03M

34.19%14.49M

100.16%14.69M

111.40%12.61M

144.38%14.21M

139.92%10.80M

70.75%7.34M

--5.96M

--5.81M

--4.50M

--4.30M

折旧摊销及损耗

0.14%699.00K

2.21%693.00K

1.69%723.00K

-25.32%767.00K

-37.46%698.00K

-45.93%678.00K

-44.45%711.00K

-20.14%1.03M

-13.89%1.12M

-16.34%1.25M

-13.75%1.28M

2.80%1.29M

7.37%1.30M

25.44%1.50M

29.95%1.48M

18.47%1.25M

82.60%1.21M

154.80%1.20M

188.38%1.14M

205.20%1.06M

148.50%661.00K

111.26%469.00K

--396.00K

--346.00K

--266.00K

--222.00K

营业利润

21.11%-30.49M

19.62%-29.14M

40.46%-21.86M

-13.58%-37.05M

-13.31%-38.65M

-15.55%-36.25M

-71.90%-36.71M

-31.82%-32.62M

-38.62%-34.11M

-37.95%-31.37M

-14.52%-21.36M

-49.28%-24.75M

-61.42%-24.61M

-40.71%-22.74M

-31.31%-18.65M

-4.65%-16.58M

-42.77%-15.25M

-104.13%-16.16M

-81.84%-14.20M

-120.92%-15.84M

-90.15%-10.68M

-40.49%-7.92M

---7.81M

---7.17M

---5.62M

---5.64M

净非营业利息收入（费用）

利息收入

-65.15%833.00K

-58.53%1.16M

-43.00%1.58M

-44.73%2.04M

-29.81%2.39M

27.95%2.80M

6.97%2.78M

35.13%3.69M

121.97%3.41M

92.78%2.19M

188.12%2.60M

411.80%2.73M

929.53%1.53M

16128.57%1.14M

44950.00%901.00K

17700.00%534.00K

2880.00%149.00K

16.67%7.00K

-33.33%2.00K

200.00%3.00K

66.67%5.00K

-93.94%6.00K

--3.00K

--1.00K

--3.00K

--99.00K

利息费用

1.45%699.00K

1.47%689.00K

-10.46%702.00K

-27.04%699.00K

-27.63%689.00K

-29.20%679.00K

-7.98%784.00K

-2.44%958.00K

-1.75%952.00K

0.31%959.00K

-12.62%852.00K

388.56%982.00K

--969.00K

--956.00K

--975.00K

--201.00K

----

特殊收入（费用）

----

-83.49%-2.00M

----

---1.09M

----

税前利润

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

除税后利润

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

持续经营利润

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

归属于母公司的净利润

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

归属于普通股东的净利润

17.84%-30.36M

16.00%-28.67M

35.83%-22.98M

-19.48%-35.71M

-16.71%-36.95M

-13.22%-34.13M

-82.58%-35.81M

-29.96%-29.89M

-31.67%-31.66M

-33.59%-30.14M

-4.75%-19.61M

-41.56%-23.00M

-59.27%-24.05M

-39.66%-22.56M

-31.85%-18.72M

-2.56%-16.25M

-41.44%-15.10M

-104.20%-16.16M

-81.89%-14.20M

-120.91%-15.84M

-90.17%-10.67M

-42.89%-7.91M

---7.81M

---7.17M

---5.61M

---5.54M

基本每股收益

17.98%-0.23

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

稀释每股收益

17.98%-0.23

16.16%-0.22

40.29%-0.18

-9.23%-0.28

-2.04%-0.28

17.16%-0.26

-43.92%-0.30

-3.83%-0.25

45.19%-0.28

65.89%-0.32

73.52%-0.21

64.06%-0.24

18.82%-0.51

-38.21%-0.93

-29.17%-0.78

-0.49%-0.67

-38.64%-0.63

-100.90%-0.67

-81.89%-0.60

-120.91%-0.67

-90.17%-0.45

-42.89%-0.34

---0.33

---0.30

---0.24

---0.23

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 TScan Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 TCRX 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

TScan Therapeutics Inc 财年末的营收是多少？



TScan Therapeutics Inc 2025 财年营收为 10.32M，高于上一财年的2.82M。

TScan Therapeutics Inc 最近一个季度的营收是多少？



TScan Therapeutics Inc 最近一个季度的营收为 1.05M，同比增长 -65.83%。

TScan Therapeutics Inc 全年的净利润是多少？



TScan Therapeutics Inc 2025 财年净利润为 -129.77M。

TScan Therapeutics Inc 上一季度的净利润是多少？



TScan Therapeutics Inc 最近一个季度的净利润为 -30.36M。

TScan Therapeutics Inc 年度营业利润是多少？



TScan Therapeutics Inc 2025 财年的营业利润为 -133.81M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。